Androgen deprivation therapy (ADT) is a common treatment for prostate cancer, aiming to lower levels of male hormones (androgens) such as testosterone, which can stimulate the growth of prostate cancer cells. While ADT can effectively slow the progression of prostate cancer, it often brings about a range of side effects due to the drastic reduction of testosterone in the patient’s body. Below, some of the most common side effects of ADT are discussed, as well as their impact on patients’ lives.
- Hot Flashes
One of the most commonly reported side effects of ADT is hot flashes. These sudden, intense feelings of warmth, often accompanied by sweating and reddened skin, are caused by hormonal changes that disrupt the body’s temperature regulation. Hot flashes can vary in frequency and intensity and may interfere with sleep, leading to fatigue and decreased quality of life.
- Sexual Dysfunction
ADT often leads to a decrease in libido (sexual desire) and can cause erectile dysfunction. The absence of testosterone, which is a hormone that is critical for sexual function, directly impacts the sexual health of men undergoing ADT. Many patients report a reduced interest in sex, and they may experience difficulty achieving or maintaining erections. These changes can affect intimate relationships and may contribute to mental health challenges like depression and anxiety.
- Bone Density Loss and Fractures
Testosterone plays an essential role in bone health, helping to maintain bone density and strength. When testosterone levels drop due to ADT, bones can become weaker and more prone to fractures. Osteoporosis, a condition characterized by low bone density and fragile bones, is a significant concern for men on long-term ADT. Bone health management strategies, including weight-bearing exercises and calcium and vitamin D supplements, are often recommended to help prevent bone loss.
- Cardiovascular Risks
ADT has been linked to increased risks for cardiovascular events, including heart attacks, strokes, and other vascular issues. Lower testosterone levels may contribute to metabolic changes that increase the risk of cardiovascular disease, such as higher cholesterol and triglyceride levels, increased body fat, and elevated blood pressure. Patients on ADT are often advised to maintain a healthy lifestyle with regular exercise and a balanced diet to reduce these risks.
- Weight Gain and Metabolic Changes
ADT can lead to an increase in body fat, particularly around the abdomen, and may also cause muscle loss. This shift in body composition, combined with possible changes in insulin sensitivity, can lead to an increased risk of diabetes and other metabolic disorders. Patients might be advised to incorporate strength training and aerobic exercise to help maintain muscle mass and support a healthy metabolism.
- Emotional and Cognitive Changes
The hormonal shifts caused by ADT can impact mood and cognition. Many men on ADT report feelings of depression, anxiety, and irritability, as well as difficulty concentrating and memory challenges. These cognitive and emotional changes are thought to result from the lack of testosterone, which plays a role in regulating mood and cognitive function. Counseling, support groups, and, in some cases, medication may be helpful in managing these symptoms.
- Fatigue
Fatigue is a frequent complaint among men undergoing ADT. This fatigue is likely due to a combination of factors, including reduced testosterone, sleep disruptions (often due to hot flashes), and the psychological stress associated with a cancer diagnosis and treatment. Managing fatigue may require a multifaceted approach, including sleep hygiene, exercise, and stress management techniques.
Conclusion
ADT can be an effective treatment for slowing the progression of prostate cancer, but it comes with a variety of side effects that can impact patients’ quality of life. Understanding these potential side effects helps patients and healthcare providers manage and mitigate the impacts of ADT, tailoring supportive therapies as needed. Through proactive strategies, including lifestyle changes and medical interventions, many side effects of ADT can be managed effectively.
References:
Basaria, S., Lieb, J., 2nd, Tang, A. M., DeWeese, T., Carducci, M., Eisenberger, M., & Dobs, A. S. (2002). Long-term effects of androgen deprivation therapy in prostate cancer patients. Clinical endocrinology, 56(6), 779–786. https://doi.org/10.1046/j.1365-2265.2002.01551.x
Carneiro, A., Sasse, A. D., Wagner, A. A., Peixoto, G., Kataguiri, A., Neto, A. S., Bianco, B. A., Chang, P., Pompeo, A. C., & Tobias-Machado, M. (2015). Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis. World journal of urology, 33(9), 1281–1289. https://doi.org/10.1007/s00345-014-1439-6
Egerdie, B., & Saad, F. (2010). Bone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options. Canadian Urological Association Journal, 4(2), 129–135. https://doi.org/10.5489/cuaj.811
Nguyen, P. L., Alibhai, S. M., Basaria, S., D’Amico, A. V., Kantoff, P. W., Keating, N. L., Penson, D. F., Rosario, D. J., Tombal, B., & Smith, M. R. (2015). Adverse effects of androgen deprivation therapy and strategies to mitigate them. European urology, 67(5), 825–836. https://doi.org/10.1016/j.eururo.2014.07.010
